Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (Middle Region) Peptide
Quick Overview for Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (Middle Region) Peptide (ABIN983152)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-RP2 antibody (Catalog #: ARP56724_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RP2 (Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2))
-
Background
-
The RP2 locus has been implicated as one cause of X-linked retinitis pigmentosa. The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin folding. Progressive retinal degeneration may therefo
Alias Symbols: KIAA0215, TBCCD2, XRP2, NME10, DELXp11.3
Protein Interaction Partner: ARL3,ARL3
Protein Size: 350 -
Molecular Weight
- 40 kDa
-
Gene ID
- 6102
-
NCBI Accession
- NM_006003, NP_008846
-
UniProt
- O75695
Target
-